Ania Owsianka
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
Owsianka, Ania; Tarr, Alexander W.; Juttla, Vicky S.; Lavillette, Dimitri; Bartosch, Birke; Cosset, François Loïc; Ball, Jonathan K.; Patel, Arvind H.
Authors
ALEXANDER TARR alex.tarr@nottingham.ac.uk
Associate Professor
Vicky S. Juttla
Dimitri Lavillette
Birke Bartosch
François Loïc Cosset
JONATHAN BALL jonathan.ball@nottingham.ac.uk
Professor of Molecular Virology
Arvind H. Patel
Abstract
Hepatitis C virus (HCV) remains a significant threat to the general health of the world's population, and there is a pressing need for the development of new treatments and preventative vaccines. Here, we describe the generation of retrovirus-based pseudoparticles (HCVpp) incorporating a panel of full-length E1E2 clones representative of the major genotypes 1 through 6, and their application to assess the reactivity and neutralizing capability of antisera and monoclonal antibodies raised against portions of the HCV E2 envelope protein. Rabbit antisera raised against either the first hypervariable region or ectodomain of E2 showed limited and strain specific neutralization. By contrast, the monoclonal antibody (MAb) AP33 demonstrated potent neutralization of infectivity against HCVpp carrying E1E2 representative of all genotypes tested. The concentration of AP33 required to achieve 50% inhibition of infection by HCVpp of diverse genotypes ranged from 0.6 to 32 μg/ml. The epitope recognized by MAb AP33 is linear and highly conserved across different genotypes of HCV. Thus, identification of a broadly neutralizing antibody that recognizes a linear epitope is likely to be of significant benefit to future vaccine and therapeutic antibody development. Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Citation
Owsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F. L., …Patel, A. H. (2005). Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. Journal of Virology, 79(17), 11095-11104. https://doi.org/10.1128/JVI.79.17.11095-11104.2005
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 1, 2005 |
Online Publication Date | Sep 1, 2005 |
Publication Date | Sep 1, 2005 |
Deposit Date | Nov 9, 2022 |
Journal | Journal of Virology |
Print ISSN | 0022-538X |
Electronic ISSN | 1098-5514 |
Publisher | American Society for Microbiology |
Peer Reviewed | Peer Reviewed |
Volume | 79 |
Issue | 17 |
Pages | 11095-11104 |
DOI | https://doi.org/10.1128/JVI.79.17.11095-11104.2005 |
Public URL | https://nottingham-repository.worktribe.com/output/3129655 |
Publisher URL | https://journals.asm.org/doi/10.1128/JVI.79.17.11095-11104.2005 |
You might also like
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation
(2014)
Journal Article
Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search